<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Front Vet Sci</journal-id><journal-id journal-id-type="pmc-domain-id">2864</journal-id><journal-id journal-id-type="pmc-domain">fvets</journal-id><journal-id journal-id-type="publisher-id">Front. Vet. Sci.</journal-id><journal-title-group><journal-title>Frontiers in Veterinary Science</journal-title></journal-title-group><issn pub-type="epub">2297-1769</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7985263</article-id><article-id pub-id-type="pmcid-ver">PMC7985263.1</article-id><article-id pub-id-type="pmcaid">7985263</article-id><article-id pub-id-type="pmcaiid">7985263</article-id><article-id pub-id-type="pmid">33768120</article-id><article-id pub-id-type="doi">10.3389/fvets.2021.641022</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Veterinary Science</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Safety and Transcriptome Analysis of Live Attenuated <italic toggle="yes">Brucella</italic> Vaccine Strain S2 on Non-pregnant <italic toggle="yes">Cynomolgus</italic> Monkeys Without Abortive Effect on Pregnant <italic toggle="yes">Cynomolgus</italic> Monkeys</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="S">Shijing</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/1169998/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names initials="H">Hui</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Q">Qiaoling</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Y">Yufu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="Q">Qiang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="W">Wei</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Qin</surname><given-names initials="Y">Yuming</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Feng</surname><given-names initials="Y">Yu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/873638/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Peng</surname><given-names initials="X">Xiaowei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="G">Guanlong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shen</surname><given-names initials="Q">Qingchun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fan</surname><given-names initials="X">Xuezheng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/413158/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ding</surname><given-names initials="J">Jiabo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/276479/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhu</surname><given-names initials="L">Liangquan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/412955/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>National/OIE Reference Laboratory for Animal Brucellosis, China Institute of Veterinary Drug Control (IVDC)</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Academy of Agriculture and Animal Husbandry Sciences</institution>, <addr-line>Hohhot</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Min Yue, Zhejiang University, China</p></fn><fn fn-type="edited-by"><p>Reviewed by: Hui Zhang, Shihezi University, China; Alaa Sewid, The University of Tennessee, United States</p></fn><corresp id="c001">*Correspondence: Jiabo Ding <email>dingjiabo@126.com</email></corresp><corresp id="c002">Liangquan Zhu <email>1367391894@qq.com</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Veterinary Infectious Diseases, a section of the journal Frontiers in Veterinary Science</p></fn></author-notes><pub-date pub-type="epub"><day>09</day><month>3</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>8</volume><issue-id pub-id-type="pmc-issue-id">374996</issue-id><elocation-id>641022</elocation-id><history><date date-type="received"><day>13</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>05</day><month>2</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>24</day><month>03</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-02 17:25:15.200"><day>02</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2021 Sun, Jiang, Li, Liu, Gao, Liu, Qin, Feng, Peng, Xu, Shen, Fan, Ding and Zhu.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Sun, Jiang, Li, Liu, Gao, Liu, Qin, Feng, Peng, Xu, Shen, Fan, Ding and Zhu</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fvets-08-641022.pdf"/><abstract><p>Brucellosis, caused by <italic toggle="yes">Brucella</italic> spp., is an important zoonotic disease leading to enormous economic losses in livestock, posing a great threat to public health worldwide. The live attenuated <italic toggle="yes">Brucella suis (B. suis)</italic> strain S2, a safe and effective vaccine, is widely used in animals in China. However, S2 vaccination in animals may raise debates and concerns in terms of safety to primates, particularly humans. In this study, we used <italic toggle="yes">cynomolgus</italic> monkey as an animal model to evaluate the safety of the S2 vaccine strain on primates. In addition, we performed transcriptome analysis to determine gene expression profiling on <italic toggle="yes">cynomolgus</italic> monkeys immunized with the S2 vaccine. Our results suggested that the S2 vaccine was safe for <italic toggle="yes">cynomolgus</italic> monkeys. The transcriptome analysis identified 663 differentially expressed genes (DEGs), of which 348 were significantly upregulated and 315 were remarkably downregulated. The Gene Ontology (GO) classification and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis indicated that these DEGs were involved in various biological processes (BPs), including the chemokine signaling pathway, actin cytoskeleton regulation, the defense response, immune system processing, and the type-I interferon signaling pathway. The molecular functions of the DEGs were mainly comprised of 2'-5'-oligoadenylate synthetase activity, double-stranded RNA binding, and actin-binding. Moreover, the cellular components of these DEGs included integrin complex, myosin II complex, and blood microparticle. Our findings alleviate the concerns over the safety of the S2 vaccine on primates and provide a genetic basis for the response from a mammalian host following vaccination with the S2 vaccine.</p></abstract><kwd-group><kwd>brucellosis</kwd><kwd>transcriptome analysis</kwd><kwd>gene expression</kwd><kwd>cynomolgus monkey</kwd><kwd>vaccine</kwd></kwd-group><counts><fig-count count="4"/><table-count count="1"/><equation-count count="0"/><ref-count count="36"/><page-count count="11"/><word-count count="6569"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Brucellosis, also known as &#8220;undulant fever,&#8221; &#8220;Mediterranean fever,&#8221; or &#8220;Malta fever,&#8221; is a significant zoonotic disease caused by <italic toggle="yes">Brucella</italic> spp. that is almost invariably transmitted by direct or indirect contact with infected animals or their products (<xref rid="B1" ref-type="bibr">1</xref>). Brucellosis remains as an important economic and public health problem in many countries and regions across the world (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Approximately 500,000 cases of human brucellosis are reported every year globally. However, the estimated incidence was believed to range from 5,000,000 to 12,500,000 annually worldwide (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). Surprisingly, in the recent years, human brucellosis incidences dramatically increased in China (<xref rid="B5" ref-type="bibr">5</xref>&#8211;<xref rid="B8" ref-type="bibr">8</xref>). From April 1, 2007 to March 31, 2017, a total of 435,108 cases of human brucellosis were reported in the Mainland China, with an average of 3,626 cases per month and an SD of 1,834 cases (<xref rid="B9" ref-type="bibr">9</xref>). A very recent report from 2013 to 2017 showed that the positive rate of the antibody against <italic toggle="yes">Brucella abortus</italic> was 44.2% in 23,381 serum samples collected from dairy cows with the clinical sign of abortion (<xref rid="B10" ref-type="bibr">10</xref>). Interestingly, the incidence rate was strongly correlated with the epidemic kinetics of human brucellosis (<italic toggle="yes">r</italic> = 0.806) (<xref rid="B10" ref-type="bibr">10</xref>), which is not too surprising as the cases of human infection with <italic toggle="yes">Brucella</italic> mainly occurred through contact with the Brucella-infected animal(s) and/or animal product(s) (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Consistently, it is generally believed that the prevention and control of human brucellosis can be satisfactorily achieved by control and/or eradication of the disease in animals (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>).</p><p>Vaccination against brucellosis remains as the most effective control measure for preventing the disease spread in the high-prevalence regions (<xref rid="B12" ref-type="bibr">12</xref>). The WHO and the World Organization for Animal Health (OIE) recommended the live attenuated vaccines Rev.1 (smooth type), S19 (smooth type), and RB51 (rough type), to fight against <italic toggle="yes">Brucella melitensis, B. abortus</italic>, and <italic toggle="yes">B. abortus</italic>, respectively. The abovementioned vaccines are currently extensively used to control animal brucellosis in many countries around the world (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). As for human brucellosis, many groups have made great efforts to develop vaccines for use in the human population; however, thus far, no safe and effective vaccine has been successfully developed and licensed for human brucellosis (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>In China, the major vaccines used for animal brucellosis include <italic toggle="yes">B. melitensis</italic> strain M5, <italic toggle="yes">Brucella suis</italic> strain S2, and <italic toggle="yes">B. abortus</italic> strain A19. The S2 strain is a live, attenuated smooth phenotype strain that was isolated from the fetus of aborted swine by the China Institute of Veterinary Drug Control (IVDC) in 1952, and it was naturally attenuated to <italic toggle="yes">B. suis</italic> vaccine by a serial passage (<xref rid="B15" ref-type="bibr">15</xref>). The advantages of the S2 vaccine include, but are not limited to, lower virulence compared to S19, M5, and Rev.1 in a wider target animal species (pig, cattle, sheep, and goat), and by convenient administration <italic toggle="yes">via</italic> the oral route (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>). In China, the S2 vaccine used in the recent decades has shown to be robust, efficacious, and safe in the vaccination of animals. Previously, our studies have shown that the S2 vaccine protected mice from challenges faced by heterologous virulent species, including M28 (<italic toggle="yes">B. melitensis</italic>), 2308 (<italic toggle="yes">B. abortus</italic>), and S1330 (<italic toggle="yes">B. suis</italic>), as evidenced by observations which showed that the immunized mice did not develop any clinical sign or tissue damage (<xref rid="B17" ref-type="bibr">17</xref>). Nonetheless, the safety of S2 in primates (e.g., humans) has remained elusive. Given that health workers (e.g., veterinarian) might be accidentally exposed to the vaccine during the vaccination of animals (<xref rid="B18" ref-type="bibr">18</xref>), there is a necessity to evaluate the safety of the S2 vaccine strain in human beings. To address this problem, in this study, we examined the safety of the S2 vaccine as well as transcriptome analysis using <italic toggle="yes">cynomolgus</italic> monkeys as an alternative animal infection model. Our results suggest that the S2 vaccine strain was safe to <italic toggle="yes">cynomolgus</italic> monkeys, and immunization with S2 resulted in an altered expression of various genes related to the biological function and the molecular activity of the host.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and Methods</title><sec><title>Ethical Statement</title><p>All animals used in this study were kept and handled in compliance with the Experimental Animal Regulation Ordinances defined by the China National Science and Technology Commission. The study was approved by the Animal Ethical Committee of the China Institute of Veterinary Drug Control under permit number, General Requirements for Laboratory Biological Safety of China, GB19489 -2008.</p></sec><sec><title>Animals</title><p>Twelve adult <italic toggle="yes">cynomolgus</italic> monkeys, including six pregnant female monkeys (2-month pregnancy, aged 3.5 years and 3.5 kg of weight) and six non-pregnant female monkeys (aged 3 years and 2.5 kg of weight), were purchased from Guangxi Province, China. Upon arrival, all monkeys were serologically tested by the Rose Bengal Plate Agglutination Test (RBPT) (<xref rid="B19" ref-type="bibr">19</xref>) and competitive ELISA (Svanova, Switzerland) and were confirmed to be <italic toggle="yes">Brucella</italic>-negative. All animals and all animal experiments were performed in an absolute negative pressure closed area conforming to BSL-3 or ABSL-3 conditions.</p></sec><sec><title>Experiment of Immunization</title><p>The lyophilized <italic toggle="yes">Brucella</italic> live S2 vaccine (with an amount of 1.22 &#215; 10<sup>10</sup> CFU and 80 doses/bottle), purchased from Qilu Animal Health Co. Ltd., China, and stored at &#8722;20&#176;C in the fridge of the National/OIE Laboratory for Brucellosis of IVDC for no more than 3 months after their arrival, was used for immunization. One bottle of stock S2 vaccine was diluted in 200 ml of phosphate buffered saline (PBS) (pH7.2) to a final concentration of 5 &#215; 10<sup>9</sup> CFU/ml. Four pregnant and four non-pregnant monkeys were randomly selected. Each monkey was subcutaneously immunized on the thigh with 1 ml (equivalent to 5 &#215; 10<sup>9</sup> CFU) of the diluted S2 vaccine, according to the Chinese Veterinary Pharmacopeia (Version 2015) (<xref rid="B19" ref-type="bibr">19</xref>). Placebo injection was performed using an identical volume of PBS (pH7.2) on two pregnant and two non-pregnant monkeys as negative controls.</p></sec><sec><title>Monitoring of Animals</title><p>All animals were monitored daily for 14 consecutive days post-immunization (p.i.). The immunization spot of the skin on the thigh was examined for any abnormal signs, such as red swelling, ulceration, and local inflammation. In addition, the behaviors and the mental status of all animals were monitored during activities such as walking, eating, drinking, as well as other similar activities. Starting from 3 days prior to immunization, the body temperature of all monkeys, except for the pregnant animals, was measured and recorded each morning and afternoon. The body temperature of the pregnant monkeys was not tested to minimize the influence on pregnancy. All pregnant monkeys were continuously monitored for abortion or any abortion-like signs after immunization until delivery. The clinical observation period of the test lasted for about 9 months till the weaning of the offspring.</p></sec><sec><title>RNA-Sequencing</title><p>On day 4 p.i., blood was collected from non-pregnant experimental monkeys. Subsequently, the peripheral blood mononuclear cells (PBMC) were isolated according to the protocol of the manufacturer (Solarbio Life Sciences, Beijing, China). Briefly, Reagents A and D in the kit were gently added into a 15 ml centrifuge tube, resulting in a layered solution. The blood sample with a volume equivalent to that of the layered solution was transferred onto the top of the layered solution and then centrifuged for 25 min at 500 g, resulting in a solution with five visible layers. The solutions in the second and third layers were gently collected and transferred into a new 15 ml centrifuge tube, and then, a 10 ml of wash solution was added and mixed gently. The mixture was centrifuged for 10 min at 250 g, and the supernatant was disposed. The pelleted cells were suspended in a 5 ml wash solution and subjected to centrifugation as above. The cells were again washed three times as above, suspended in a 5 ml wash solution and used for total RNA extraction and purification. The purity, molar concentration, and the integrity of the RNA were determined by Nanodrop (ND 1000 spectrophotometer Thermo Scientific, Wilmington, USA), Qubit 2.0 (Thermo Fisher Scientific, MA, USA), and Aglient 2100 (Agilent Technologies Inc, CA, USA), respectively, to ensure that the samples used for the transcriptomic sequencing were qualified. Subsequently, a cDNA library was constructed using the extracted RNA. Briefly, the eukaryotic mRNA was enriched using magnetic beads and Oligo (dT). A fragmentation buffer was then added to randomly disrupt the mRNA. The first cDNA strand was synthesized utilizing random hexamers as primers and mRNA as a template. The second cDNA strand was synthesized after adding a buffer, dNTPs, RNase H, and a DNA polymerase. The cDNA of each sample was purified by AMPure XP beads (Beckman Coulter, CA, USA) and subjected to end repair, A-tail addition, and adapter sequencing. The fragments with appropriate size were selected by AMPure XP beads. The concentration and size of the fragments inserted in the library were measured using Qubit 2.0 and Agilent 2100, respectively. Finally, PCR enrichment was performed to construct the cDNA library for each sample using the NEBNext Ultra Directional RNA Library Prep Kit for Illumina (New England BioLabs, MA, USA) as recommended by the manufacturer. The accurate concentration of the library was determined by using a real-time PCR. High-throughput sequencing was conducted by the HiSeq X Ten System with a read length of PE150. Sequencing and subsequent bioinformatics analyses were completed at Biomarker Technologies Co., Ltd, Beijing, China.</p></sec><sec><title>Identification of Differentially Expressed Genes (DEGs)</title><p>Identification and characterization of DEGs were achieved based on the results of differential expression analysis <italic toggle="yes">via</italic> EBSeq algorithm to filter DEGs with a log-fold expression change (log2FC &gt; 0.585 or &lt; &#8722;0.585) using a threshold of false discovery rates (FDR &lt; 0.05), as previously described (<xref rid="B17" ref-type="bibr">17</xref>).</p></sec><sec><title>Gene Ontology (GO) Analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG)</title><sec><title>Pathway Analysis</title><p>Comparative transcriptome analyses, employing the GO classification and the KEGG pathway analysis approaches, were performed. The gene products were annotated in terms of a biological function and metabolic pathways. The biological function, signal transduction, and metabolic pathways of the DEGs were analyzed.</p></sec><sec><title>Quantitative Reverse-Transcription PCR</title><p>To validate the difference of gene expression profiling, a quantitative reverse-transcription PCR (qRT-PCR) was performed. A total of 23 DEGs were randomly selected, including 12 upregulated and 11 downregulated genes. The targeted genes and the designed primers used for qRT-PCR are shown in <xref rid="T1" ref-type="table">Table 1</xref>. Briefly, the mRNAs from samples of six non-pregnant monkeys were extracted and used for the following qRT-PCR system. The reaction mixture was prepared for reverse transcription, including 5 &#215; PrimeScript<sup>TM</sup> RT Master Mix [containing PrimeScriptRTase, RNase inhibitor, Random Hex Primer, Oligo (dT), and dNTPs] (Takara Bio, Dalian, China) of 2 &#956;l, Total RNA of 5 &#956;l, and sterile RNase-free H<sub>2</sub>O of 3 &#956;l. The mixture was incubated at 37&#176;C in a water bath for 15 min for reverse transcription, followed by incubation at 85&#176;C in a water bath for 5 s for the inactivation of reverse transcriptase. The cDNA was 10-fold diluted using a sterile RNase-free H<sub>2</sub>O and used for PCR amplification. The PCR reaction system consisted of 10 &#956;l 2 &#215; TB Green Premix Ex Taq (Tli RNase H Plus), 0.4 &#956;l 50 &#215; ROX Reference Dye II, and 6 &#956;l sterile RNase-free H<sub>2</sub>O. The mixture was incubated at 95&#176;C for 30 s and then subjected to 40 cycles of incubation at 95&#176;C for 5 s and 60&#176;C for 34 s in the LightCycler 2.0 system (Roche Life Sciences, Basel, Switzerland). To normalize the expression, the &#946;-actin of <italic toggle="yes">cynomolgus</italic> monkey was used as an internal amplification control, for which the forward primer ACTB-1 (5&#8242;-CGCCATGGATGATGATATCGC-3&#8242;C) and the reverse primer ACTB-2 (5&#8242;-ATCCTTCTGACCCATGCCCA-3&#8242;A) were used, and the preparation of the same mixture as well as thermocycling were performed.</p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Transcriptional level of 23 randomly selected genes by RNA-seq and qRT-PCR.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Gene</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Change of regulation</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Sequence (5'-3')</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Fragment length (bp)</bold></th><th valign="top" align="left" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1"><bold>Log</bold><sub><bold><bold>2</bold></bold></sub>
<bold>FC (S2 vaccinated monkeys vs. negative control</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Annotation</bold></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>RNA-seq</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>qRT-PCR</bold></th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">T-DYSF</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">GGGAACCGCTACCATCTACG</td><td valign="top" align="center" rowspan="1" colspan="1">246</td><td valign="top" align="center" rowspan="1" colspan="1">5.1790</td><td valign="top" align="center" rowspan="1" colspan="1">4.0874</td><td valign="top" align="left" rowspan="1" colspan="1">Dysferlin isoform X1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GTCGTACAGCTCCACCACAA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-OASL</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">AGACGGCCAACCTGTTAAGG</td><td valign="top" align="center" rowspan="1" colspan="1">162</td><td valign="top" align="center" rowspan="1" colspan="1">3.2444</td><td valign="top" align="center" rowspan="1" colspan="1">1.6045</td><td valign="top" align="left" rowspan="1" colspan="1">2'-5'-oligoadenylate synthase-like protein</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TCCGGTGCTCTATGGGATGA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-GBP1 (LOC)</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">TTCCTGTCACCCCTACCCAA</td><td valign="top" align="center" rowspan="1" colspan="1">130</td><td valign="top" align="center" rowspan="1" colspan="1">3.1717</td><td valign="top" align="center" rowspan="1" colspan="1">3.7587</td><td valign="top" align="left" rowspan="1" colspan="1">Guanylate-binding protein 1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TTGATCACTGTACTGCATGCCT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-APOL6</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">ATGACCAAGAATGCTCGCCT</td><td valign="top" align="center" rowspan="1" colspan="1">224</td><td valign="top" align="center" rowspan="1" colspan="1">3.1460</td><td valign="top" align="center" rowspan="1" colspan="1">4.0167</td><td valign="top" align="left" rowspan="1" colspan="1">Apolipoprotein L6</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GGCTCAGAGGCCTAACAGTA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-GBP2</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">TGGACCAAACGTTCCAGAGG</td><td valign="top" align="center" rowspan="1" colspan="1">234</td><td valign="top" align="center" rowspan="1" colspan="1">2.8084</td><td valign="top" align="center" rowspan="1" colspan="1">2.7357</td><td valign="top" align="left" rowspan="1" colspan="1">Uncharacterized protein LOC105761007</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CCTTCCTTGGCACCTGGTAG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-IFIT2</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">AGAACGCCATTGACCCTCTG</td><td valign="top" align="center" rowspan="1" colspan="1">106</td><td valign="top" align="center" rowspan="1" colspan="1">2.7773</td><td valign="top" align="center" rowspan="1" colspan="1">4.3010</td><td valign="top" align="left" rowspan="1" colspan="1">Interferon(IFN)-induced protein with tetratricopeptide repeats 2-like</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TCGCCTTCTTCACGCATCTT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-WARS</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">TGCTGAACGAAGCCTCTGAC</td><td valign="top" align="center" rowspan="1" colspan="1">175</td><td valign="top" align="center" rowspan="1" colspan="1">2.4982</td><td valign="top" align="center" rowspan="1" colspan="1">3.2010</td><td valign="top" align="left" rowspan="1" colspan="1">Tryptophan&#8211;tRNA ligase</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CAAAAGTGATGGCTTTGACGCA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-LOC102143453</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">AAACTTGGAGCTGTGGTGCT</td><td valign="top" align="center" rowspan="1" colspan="1">118</td><td valign="top" align="center" rowspan="1" colspan="1">2.4676</td><td valign="top" align="center" rowspan="1" colspan="1">5.3050</td><td valign="top" align="left" rowspan="1" colspan="1">Guanylate-binding protein 6</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TGGGGGCTGTCCTTTCTAGT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-IRF7</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">CGACTGTGGCACCCAGG</td><td valign="top" align="center" rowspan="1" colspan="1">105</td><td valign="top" align="center" rowspan="1" colspan="1">2.2691</td><td valign="top" align="center" rowspan="1" colspan="1">6.5161</td><td valign="top" align="left" rowspan="1" colspan="1">IFN regulatory factor 7 isoform X1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GTGTGACTGCAGGTATGGCT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-APOL2</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">AGCAGGGGAGTGGTTAATGC</td><td valign="top" align="center" rowspan="1" colspan="1">157</td><td valign="top" align="center" rowspan="1" colspan="1">2.1390</td><td valign="top" align="center" rowspan="1" colspan="1">3.7849</td><td valign="top" align="left" rowspan="1" colspan="1">Apolipoprotein L3-like isoform</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CCCCTCTATTCCTCCCCCAA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-LITAF</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">GCGTCTGCAGCAAAGGTAAA</td><td valign="top" align="center" rowspan="1" colspan="1">168</td><td valign="top" align="center" rowspan="1" colspan="1">2.0562</td><td valign="top" align="center" rowspan="1" colspan="1">0.6692</td><td valign="top" align="left" rowspan="1" colspan="1">Lipopolysaccharide-induced tumor necrosis factor-alpha factor isoform X1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CTGTCACAAGCCCCGTAGTT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-CTSD</td><td valign="top" align="left" rowspan="1" colspan="1">Up</td><td valign="top" align="left" rowspan="1" colspan="1">GGCGAGTACATGATCCCCTG</td><td valign="top" align="center" rowspan="1" colspan="1">111</td><td valign="top" align="center" rowspan="1" colspan="1">1.1492</td><td valign="top" align="center" rowspan="1" colspan="1">2.3983</td><td valign="top" align="left" rowspan="1" colspan="1">Cathepsin D</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CGACACCTTGAGCGTGTAGT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-RPL18A</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">GCTTCTGGCACACTACGAGA</td><td valign="top" align="center" rowspan="1" colspan="1">202</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.6245</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;2.6684</td><td valign="top" align="left" rowspan="1" colspan="1">60S ribosomal protein L18a</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TCTCAAACACCTGCCCACAG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T- RPS13</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">GAGGTCACTTCCTGCGTGTT</td><td valign="top" align="center" rowspan="1" colspan="1">186</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.6301</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.1930</td><td valign="top" align="left" rowspan="1" colspan="1">Predicted: 40S ribosomal protein S13</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GCTCCTTCACGTCGTCAGAT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T- FAM102A</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">GGAGACCCCTGCTTCAAGAC</td><td valign="top" align="center" rowspan="1" colspan="1">138</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.6932</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.9073</td><td valign="top" align="left" rowspan="1" colspan="1">Protein FAM102A</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GGACCCAGTCAAGGAGTTGG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T- ZFP36L2</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">ACCAGCAGCTATCAACCACC</td><td valign="top" align="center" rowspan="1" colspan="1">205</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.7100</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;3.0286</td><td valign="top" align="left" rowspan="1" colspan="1">Zinc finger protein 36, C3H1 type-like 2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">ACCTATGGGCTGAGGGCTAA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-CXCR4</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">GCTGTTGGCTGAAAAGGTGG</td><td valign="top" align="center" rowspan="1" colspan="1">204</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.7495</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;1.7388</td><td valign="top" align="left" rowspan="1" colspan="1">B-cell CLL/lymphoma 9-like protein isoform X1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GACAGGATGGCGATACCAGG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-GNLY</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">CTCCCACATCGTGGAGACCTG</td><td valign="top" align="center" rowspan="1" colspan="1">237</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.8416</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;3.7190</td><td valign="top" align="left" rowspan="1" colspan="1">c-X-C chemokine receptor type 4</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TGTAGGCCTGAGGAAACGCA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-LOC102143791</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">GAGCTCAGGACATTTTCTTCCC</td><td valign="top" align="center" rowspan="1" colspan="1">211</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.9605</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;2.6477</td><td valign="top" align="left" rowspan="1" colspan="1">Integrin-alpha FG-GAP repeat-containing protein 2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GAGGCAGGCCTTCGCAAAAA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-ICAM2</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">TTGTGAACTGGGCAGCTGTG</td><td valign="top" align="center" rowspan="1" colspan="1">105</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;1.0497</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.2942</td><td valign="top" align="left" rowspan="1" colspan="1">Granulysin</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GAAGGGCTGCCCCTGTG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-RPL29</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">AGAGGACGGGTGCAGACA</td><td valign="top" align="center" rowspan="1" colspan="1">139</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;1.1085</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;1.3181</td><td valign="top" align="left" rowspan="1" colspan="1">MHC class I heavy chain</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CTCAGGAACTTGGGGTCCAC</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-BCL9L</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">GGTATTGAGATCAAGGCGTCCA</td><td valign="top" align="center" rowspan="1" colspan="1">225</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;1.2431</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;2.7988</td><td valign="top" align="left" rowspan="1" colspan="1">Intercellular adhesion molecule 2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TGGAGCACGGACTCAGGAAT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T-ITFG2</td><td valign="top" align="left" rowspan="1" colspan="1">Down</td><td valign="top" align="left" rowspan="1" colspan="1">GTCCCGAACATCTCACAGGG</td><td valign="top" align="center" rowspan="1" colspan="1">239</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;1.4577</td><td valign="top" align="center" rowspan="1" colspan="1">&#8722;0.5008</td><td valign="top" align="left" rowspan="1" colspan="1">60S ribosomal protein L29</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CAGCACCACATCTCGGGTAG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>Clinical Assessment</title><p>On the day of immunization, very slight swelling was observed at the injection site of the thigh skin of two <italic toggle="yes">cynomolgus</italic> monkeys (data not shown). However, these observatory signs rapidly vanished on the next day p.i. Afterward, no abnormal clinical manifestation was observed on the skin of the immunized monkeys until the end of the experiment, indicating that S2 immunization did not result in deleterious clinical effects at the injection spot of the monkeys.</p><p>The body temperature of all non-pregnant <italic toggle="yes">cynomolgus</italic> monkeys was detected daily during the whole experimental period, starting from 3 days before immunization until 14 days p.i. The results indicated that the temperature of all non-pregnant monkeys monitored throughout the entire experimental period fell into a normal level, ranging from 35.5&#176;C to 37.5&#176;C, and no difference was observed between monkeys immunized with S2 and those inoculated with PBS (<xref ref-type="fig" rid="F1">Figure 1</xref>). These results demonstrated that immunization of S2 and PBS did not lead to abnormal change in the body temperature of the non-pregnant monkeys.</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Results of body temperature monitoring of <italic toggle="yes">cynomolgus</italic> monkeys immunized with the S2 vaccine and inoculated with phosphate buffered saline (PBS) (negative control). The body temperature of all non-pregnant <italic toggle="yes">cynomolgus</italic> monkeys, including the animals immunized with the S2 vaccine and those inoculated with PBS, was detected daily during the entire experimental period, starting from 3 days prior to injection till 14 days post-immunization (p.i.). <bold>(A)</bold> Indicated the results of body temperature of all the animals detected in the morning, and <bold>(B)</bold> showed the results obtained in the afternoon. The bottom line of normal body temperature (35.5&#176;C) and the top line of normal body temperature (35.7&#176;C) were indicated.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fvets-08-641022-g0001.jpg"/></fig><p>The behavior of all monkeys was monitored daily during the whole experimental period. Our results showed that none of the animals exhibited any abnormal behavior (data not shown). No difference was observed between the S2-vaccinated and PBS-inoculated animals in terms of behavior over the whole experimental period, including activities such as drinking and eating. These results suggested that the S2 vaccination did not alter the behavior of any <italic toggle="yes">cynomolgus</italic> monkeys.</p><sec><title>Monitoring of Abortion</title><p>A previous study reported that natural infection of <italic toggle="yes">Brucella</italic> spp. frequently resulted in abortion (<xref rid="B1" ref-type="bibr">1</xref>). Therefore, the clinical sign of abortion is an important indicator for the infection of <italic toggle="yes">Brucella</italic> spp. In order to understand whether immunization of the S2 vaccine leads to abortion, we inoculated four pregnant <italic toggle="yes">cynomolgus</italic> monkeys with S2 and then continuously monitored them on a daily basis for abortion till delivery. None of the immunized monkeys got aborted after vaccination. Moreover, the offspring of monkeys did not exhibit abnormal behaviors or clinical signs (data not shown), thus suggesting that the S2 vaccination did not cause abortion in the <italic toggle="yes">cynomolgus</italic> monkeys.</p></sec></sec><sec><title>Transcriptomic Analysis of S2-Vaccinated and PBS-Inoculated <italic toggle="yes">Cynomolgus</italic> Monkeys</title><p>To identify the genetic factors correlating with S2 immunization, changes of the transcriptomic profile of gene expression in <italic toggle="yes">cynomolgus</italic> monkeys immunized with S2 were examined by a transcriptomic analysis. The same analysis was also performed on the negative control samples collected from <italic toggle="yes">cynomolgus</italic> monkeys inoculated with PBS. RNA extracted from the blood of non-pregnant monkeys was used as a template for the construction of a library, followed by a transcriptomic RNA-seq. We did not collect blood from pregnant <italic toggle="yes">cynomolgus</italic> monkeys, considering that the fixation of animal and blood collection may lead to unexpected abortion. Identification and analysis of DEGs were performed based on the results of EBSeq algorithm analyses. On day 4 p.i., transcriptomic sequencing of the mRNA of 15,009 genes derived from the S2-immunized group identified 663 DEGs (log2FC &gt; 0.585 or &lt; &#8722;0.585 and FDR &lt; 0.05), compared to the negative control group (in which animals were inoculated with PBS), including 348 significantly upregulated genes and 315 significantly downregulated genes (<xref ref-type="fig" rid="F2">Figure 2</xref>). Among these DEGs, the highest-ranked upregulated genes included DEXH (Asp-Glu-X-His) box polypeptide 58 (DHX58), integrin-alpha 2 (ITGA2), and 2'-5'-oligoadenylate synthetase 2 (OAS2), whereas the lowest downregulated genes comprised of myosin VIIA (MYO7A), Usher syndrome 1C (USH1C), and chemokine (C-X-C motif) receptor 6 (CXCR6) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Heatmap for RNA-sequencing (RNA-seq) data. Blood of four <italic toggle="yes">cynomolgus</italic> monkeys immunized with the S2 vaccine and that of two <italic toggle="yes">cynomolgus</italic> monkeys inoculated with PBS (negative control) were collected and used for RNA extraction. A cDNA library was constructed and then transcriptomic RNA-seq was performed. Red and blue pixels indicate upregulated and downregulated genes, respectively. Genes were categorized into different clusters based on the generated dendrogram.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fvets-08-641022-g0002.jpg"/></fig></sec><sec><title>Gene Ontology <italic toggle="yes">Category</italic></title><p>The term GO has three ontologies, including the biological process (BP), molecular function (MF), and cellular component (CC). The sequences of these aforementioned DEGs were analyzed employing a GO analytical approach. Our investigations based on the GO functional enrichment analysis revealed that the 663 DEGs were mainly involved in various BPs, including defense response, immune system processing, and the type-I interferon signaling pathway (<xref ref-type="fig" rid="F3">Figure 3</xref>). The MF of these DEGs included 2'-5'-oligoadenylate synthetase activity, double-stranded RNA (dsRNA) binding, and actin-binding (<xref ref-type="fig" rid="F3">Figure 3</xref>). In addition, these genes were correlated with C, including integrin complex, myosin II complex, and blood microparticle (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Gene ontology (GO) analysis for differentially expressed genes (DEGs). Results are grouped by three main functional categories, including <bold>(A)</bold> the biological process (BP), <bold>(B)</bold> molecular function (MF), and <bold>(C)</bold> cellular component (CC).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fvets-08-641022-g0003.jpg"/></fig></sec><sec><title>Pathway Analysis</title><p>Next, we sought to analyze the above DEGs <italic toggle="yes">via</italic> the KEGG pathway analysis. As shown in <xref ref-type="fig" rid="F4">Figure 4</xref>, the DEGs were mainly related to the chemokine signaling pathways, signaling pathways after measles virus, and the infection of influenza A virus. Interestingly, the upregulated genes were enriched in pathways relating to the regulation of actin cytoskeleton, as well as the infection by measles virus and influenza A virus, whereas the enriched downregulated genes were relevant to cell adhesion molecules, cytokine&#8211;cytokine receptor interaction, and chemokine signaling pathway.</p><fig id="F4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>Analysis of DEGs through the KEGG pathway. <bold>(A)</bold> The KEGG pathway analysis of all DEGs. <bold>(B)</bold> The KEGG pathway analysis of upregulated expressed genes. <bold>(C)</bold> The KEGG pathway analysis of downregulated expressed genes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fvets-08-641022-g0004.jpg"/></fig><sec><title>Quantitative Reverse-Transcription Polymerase Chain Reaction</title><p>To validate the RNA-seq results, a total of 23 DEGs, including 12 significantly upregulated genes and 11 significantly downregulated genes, were randomly selected and quantified by qRT-PCR. The &#946;-actin gene was simultaneously detected and analyzed as an internal control. As outlined in <xref rid="T1" ref-type="table">Table 1</xref>, the expression levels of the 23 selected genes in the qRT-PCR exhibited a very similar profile to that of the RNA-seq, confirming the consistency of results obtained in the RNA-seq and the qRT-PCR.</p></sec></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Brucellosis is a worldwide zoonotic infectious disease caused by the members of the genus, <italic toggle="yes">Brucellae</italic>, which are circulating in many countries, especially in the Mediterranean basin, Asia, the Middle East, and in the Central and South America (<xref rid="B20" ref-type="bibr">20</xref>). Brucellosis, which leads to substantial economic losses in the animal industry, has a significant impact on the health of human populations, as well as has an influence on the structure of the whole society around the world, e.g., public safety, food hygiene, and foreign trade (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). A recent report described the analyses of the species distribution, host lineage profiles, genetic relatedness, and the epidemiological correlation of the <italic toggle="yes">Brucella</italic> species in countries along the Silk Road. The authors concluded that numerous animal reservoirs were a potential reason for the continuous circulation of the brucellosis in the examined countries, while the <italic toggle="yes">B. abortus</italic> strains were dominated in these countries and spreading within the national borders (<xref rid="B23" ref-type="bibr">23</xref>). In addition, using descriptive analysis and meta-analysis approaches, Zhou et al. reported very recently that dogs and yaks were the leading reservoirs and emerging hosts for <italic toggle="yes">Brucella</italic> transmission in China (<xref rid="B24" ref-type="bibr">24</xref>). Meanwhile, the authors inferred that humans probably get infected along with different kinds of animal species, among which the sheep and goats were likely at the highest risks (<xref rid="B24" ref-type="bibr">24</xref>). The aforementioned studies, as well as the ligatures, e.g., a recent report from our collaborators (<xref rid="B25" ref-type="bibr">25</xref>), consistently demonstrated the significance of the One Health concept and recommended implementing it to disrupt the <italic toggle="yes">Brucella</italic> transmission chain between animals and humans, as well as to strengthen the close collaboration between the local and public partnerships.</p><p>It has been well-documented that vaccination plays a critical role in the prevention and control of brucellosis (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B17" ref-type="bibr">17</xref>). However, so far, there has been no licensed vaccine for brucellosis in human, and currently, the available animal vaccines may cause huge concern and disease; therefore, they were considered unsuitable for use in human populations (<xref rid="B26" ref-type="bibr">26</xref>). Therefore, the search for brucellosis vaccine for humans has continued to raise the interests of the researchers. As far as vaccines against animal brucellosis are concerned, there are currently a variety of vaccines available in the world. The <italic toggle="yes">Brucella</italic> live vaccines, S19, Rev.1, and RB51, which are widely used in different regions of the world, have been demonstrated to effectively offer immune protection against brucellosis (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Nevertheless, the negative implications of these vaccines, such as the residual virulence in the host, diagnostic interference, and the pathogenic effect to human health, in particular, have remained poorly understood, thus raising doubts and concerns in the implementation of these vaccines in the field conditions (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B27" ref-type="bibr">27</xref>). For instance, a previous study showed that although the vaccine strain S19 was of low virulence for cattle, the vaccination of pregnant cows resulted in abortion with incidence rate ranging from &lt;1&#8211;2.5% under field conditions (<xref rid="B12" ref-type="bibr">12</xref>). These concerns and problems prompted us to evaluate the safety of live attenuated <italic toggle="yes">Brucella</italic> vaccine strain in primates. Given that the virulence of the S2 strain was the lowest compared to other <italic toggle="yes">Brucella</italic> vaccine strains (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B28" ref-type="bibr">28</xref>), we explored it to determine the safety of S2 on <italic toggle="yes">cynomolgus</italic> monkeys.</p><p>The S2 vaccine is extensively used in China to control brucellosis in goats, sheep, and cattle. In our previous study, we demonstrated that the S2 vaccine could protect mice from virulent challenge by heterologous strains, including <italic toggle="yes">B. militensis</italic> M28, <italic toggle="yes">B. abortus</italic> 2308, and <italic toggle="yes">B. suis</italic> 1,330 (<xref rid="B17" ref-type="bibr">17</xref>). However, the safety of S2 in primates, especially humans, has remained undetermined. The possibility of the infection of S2 vaccine strain in a group of veterinary professionals due to unexpected reasons, such as accident exposure while handling the vaccine, should not be ignored, considering the fact that S2 is a live vaccine. Accordingly, the safety of the S2 vaccine to humans needs to be comprehensively evaluated. In addition, it has been well-documented that cases of <italic toggle="yes">Brucella</italic> infection in human populations were predominantly caused by animals or animal products infected with <italic toggle="yes">Brucella</italic> (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Thus, prevention, control, and elimination of <italic toggle="yes">Brucella</italic> in animals would be extremely beneficial to the control of human brucellosis. Therefore, in the present study, we sought to determine the safety of the S2 strain to humans using the <italic toggle="yes">cynomolgus</italic> monkey infection model. Our results clearly showed that the S2 vaccine was indeed safe to <italic toggle="yes">cynomolgus</italic> monkeys, as evidenced by observations that all monkeys immunized with the S2 strain neither showed any abnormal behaviors nor suffered abortion. This evidence might alleviate concerns of grass-root veterinarians over the accidental exposure to the S2 vaccine strain when using it to immunize animals in practice. In other words, our data would enhance the confidence of professionals in the use of the S2 vaccine in the field conditions. To the best of our knowledge, this is the first report of evaluation on live attenuated <italic toggle="yes">Brucella</italic> spp. vaccine in <italic toggle="yes">cynomolgus</italic> monkeys, which is an ideal primate species as it is genetically close to human beings. Furthermore, given that the S2 strain was highly attenuated in mice (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B28" ref-type="bibr">28</xref>) and was safe to <italic toggle="yes">cynomolgus</italic> monkeys as described here, it might be feasible to further attenuate the S2 strain while keeping its immunogenicity unchanged using genetic engineering, thus making it a potential vaccine candidate for use in human populations.</p><p>Very recently, a total of 1,205 DEGs were identified between artificially induced rough-mutant <italic toggle="yes">Brucella</italic> strain RM57 and its parent strain, M1981, <italic toggle="yes">via</italic> the transcriptome analysis (<xref rid="B29" ref-type="bibr">29</xref>). The goal of this study was to evaluate the safety of the live vaccine S2 in human utilizing <italic toggle="yes">cynomolgus</italic> monkeys as an alternative model, as well as performing the transcriptome analysis of the peripheral blood collected from S2-immunized <italic toggle="yes">cynomolgus</italic> monkeys to obtain information of the immune response relevant to the safety of the S2 vaccine at an early stage. Toward this end, instead of using the lymph tissues or organs, in this study, we took an alternative way, i.e., using the peripheral blood to isolate lymphocytes for transcriptomic analysis. We did not examine the lymph nodes for the innate immune response due to our concern that the fixation of animals and the collection of blood may lead to unexpected abortion, and as a consequence, it may interfere with our evaluations on the safety of the S2 vaccine, since abortion is an important parameter in our evaluation in this study. The use of the peripheral blood for the isolation of lymphocytes for transcriptomic analysis is not new, as the use of the peripheral blood from pigs (<xref rid="B30" ref-type="bibr">30</xref>), dogs (<xref rid="B31" ref-type="bibr">31</xref>), Chinese geese (<xref rid="B32" ref-type="bibr">32</xref>), and humans (<xref rid="B33" ref-type="bibr">33</xref>&#8211;<xref rid="B35" ref-type="bibr">35</xref>), including patients with COVID-19 (<xref rid="B36" ref-type="bibr">36</xref>), have been well-documented.</p><p>Previously, comparative genomic analysis between S2 and the virulent strain 1,330 was reported, and 59 different open reading frames (ORFs) between these two strains were identified, several of which were demonstrated to be related to the virulence of <italic toggle="yes">Brucella</italic> spp., such as outer membrane autotransport and eryD (<xref rid="B16" ref-type="bibr">16</xref>). To further uncover the mechanism underlying the virulence attenuation of S2, our colleagues recently characterized the transcriptional profile of S2 and <italic toggle="yes">B. suis</italic> 1,330 infected murine macrophages by the transcriptome analysis, showing that the expression of 440 genes was significantly enriched, involving the innate immune response, phagocytosis, recognition, and inflammatory response, as well as the <italic toggle="yes">Staphylococcus aureus</italic> infection pathway and the NF-kappa B signaling pathway (<xref rid="B28" ref-type="bibr">28</xref>). In addition, our findings indicated that the DEGs related to the S2 immunization/infection were different between murine macrophages and monkeys (<xref rid="B28" ref-type="bibr">28</xref>). In order to further ascertain the host cellular response and genetic factors associated with S2 vaccination in mammals, in this study, we performed a comparative transcriptome analysis on blood cells collected from S2-immunized <italic toggle="yes">cynomolgus</italic> monkeys. We demonstrated that S2 vaccination of monkeys resulted in altered levels of the expression of 663 genes relevant to various MFs and biological functions of the host organism, including actin cytoskeleton regulation and binding, defense response, 2'-5'-oligoadenylate synthetase activity, dsRNA binding, the type-I interferon signaling pathway, and the chemokine signaling pathway. These results enhanced our understanding of the immune response of the mammalian species upon S2 vaccination as well as the mechanism of virulence attenuation of the S2 vaccine strain.</p><p>The data reported in the present study shed light on the safety of the S2 vaccine. Yet, there are still some limitations in our study. First, only limited numbers of <italic toggle="yes">cynomolgus</italic> monkeys were used, resulting in insufficient statistical analyses and comparisons. Second, the blood of pregnant <italic toggle="yes">cynomolgus</italic> monkeys was not collected and tested; thus, we might have missed some important information about the transcriptomic profile of the pregnant <italic toggle="yes">cynomolgus</italic> monkeys. Third, we did not measure the parameters relevant to the host immune response, such as the humoral immunity and the cell-mediated immune response. Fourth, RT-PCR detecting <italic toggle="yes">Brucella</italic> in the collected peripheral blood was not performed. These outcomes may suggest that only a partial situation of the safety of the S2 vaccine was truly reflected. Despite these limitations, we believe that our results would enhance the understanding of the safety of the S2 vaccine. Further studies with improved experimental design and larger sample size are warranted to further verify the reported results.</p></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>This study provides evidence on the safety of the <italic toggle="yes">Brucella</italic> S2 vaccine strain on <italic toggle="yes">cynomolgus</italic> monkeys, enhancing the understanding of the pathogenicity of S2 in human. The work offers insights into the molecular basis of the host gene regulation in response to S2 vaccination.</p></sec><sec sec-type="data-availability" id="s6"><title>Data Availability Statement</title><p>The datasets presented in this study can be found in online repositories.The names of the repository/repositories and accession number(s) can be found below: NCBI Gene Expression Omnibus, Accession No: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE165283"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="GSE165283">GSE165283</ext-link></ext-link>.</p></sec><sec id="s7"><title>Ethics Statement</title><p>The animal study was reviewed and approved by Animal Ethics Committee of China Institute of Veterinary Drug Control, China.</p></sec><sec id="s8"><title>Author Contributions</title><p>LZ, JD, and YQ conceived and designed the experiments. SS, HJ, QL, and YL performed the experiments, analyzed the data, and prepared figures and tables. QG, YF, XP, GX, QS, and XF performed the experiments and analyzed the data. All authors reviewed the drafts of the paper and approved the final draft.</p></sec><sec sec-type="COI-statement" id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We thank Biomarker Technologies Co., Ltd for their support in the bioinformatics analyses. We also thank NovelBio Bio-Pharm Technology Co., Ltd for their support in the data analyses.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the National Key Research and Development Program of China (No. 2017YFD0500901) and Major Science and Technology Projects of Xinjiang Construction Corps (No. 2017AA003).</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorbel</surname><given-names>MJ</given-names></name></person-group>. <source>Brucellosis in Humans and Animals</source>. World Health Organization (<year>2006</year>)</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>F</given-names></name><name name-style="western"><surname>Zinsstag</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Orkhon</surname><given-names>D</given-names></name><name name-style="western"><surname>Chimid-Ochir</surname><given-names>G</given-names></name><name name-style="western"><surname>Hutton</surname><given-names>G</given-names></name><name name-style="western"><surname>Cosivi</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Human health benefits from livestock vaccination for brucellosis: case study</article-title>. <source>Bull World Health Organ</source>. (<year>2003</year>) <volume>81</volume>:<fpage>867</fpage>&#8211;<lpage>76</lpage>.<pub-id pub-id-type="pmid">14997239</pub-id><pub-id pub-id-type="pmcid">PMC2572379</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godfroid</surname><given-names>J</given-names></name><name name-style="western"><surname>Al Dahouk</surname><given-names>S</given-names></name><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name><name name-style="western"><surname>Roth</surname><given-names>F</given-names></name><name name-style="western"><surname>Matope</surname><given-names>G</given-names></name><name name-style="western"><surname>Muma</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>A &#8220;One Health&#8221; surveillance and control of brucellosis in developing countries: moving away from improvisation</article-title>. <source>Comp Immunol Microbiol Infect Dis</source>. (<year>2013</year>) <volume>36</volume>:<fpage>241</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.cimid.2012.09.001</pub-id><pub-id pub-id-type="pmid">23044181</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hull</surname><given-names>NC</given-names></name><name name-style="western"><surname>Schumaker</surname><given-names>BA</given-names></name></person-group>. <article-title>Comparisons of brucellosis between human and veterinary medicine</article-title>. <source>Infect Ecol Epidemiol</source>. (<year>2018</year>) <volume>8</volume>:<fpage>1500846</fpage>. <pub-id pub-id-type="doi">10.1080/20008686.2018.1500846</pub-id><pub-id pub-id-type="pmid">30083304</pub-id><pub-id pub-id-type="pmcid">PMC6063340</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name></person-group>. <article-title>An exploratory study of factors associated with human brucellosis in mainland China based on time-series-cross-section data from 2005 to 2016</article-title>. <source>PLoS ONE</source>. (<year>2019</year>)<volume>14</volume>:<fpage>e0208292</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0208292</pub-id><pub-id pub-id-type="pmid">31199806</pub-id><pub-id pub-id-type="pmcid">PMC6568380</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group>. <article-title>Reasons and prevention and control measures for the high brucellosis incidence</article-title>. <source>Disease Surveillance</source>. (<year>2010</year>)<volume>25</volume>:<fpage>341</fpage>&#8211;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-010-9446-4</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>GX</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Ke</surname><given-names>YH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YF</given-names></name><name name-style="western"><surname>Xu</surname><given-names>XR</given-names></name></person-group>. <article-title>Literature analysis of brucellosis epidemic situation and research progress in China from 2000 to 2010</article-title>. <source>Chinese J Zoonoses.</source> (<year>2012</year>) <volume>2012</volume>:<fpage>1178</fpage>&#8211;<lpage>84</lpage>.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Changing epidemiology of human brucellosis, China, 1955-2014</article-title>. <source>Emerg Infect Dis</source>. (<year>2017</year>) <volume>23</volume>:<fpage>184</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.3201/eid2302.151710</pub-id><pub-id pub-id-type="pmid">28098531</pub-id><pub-id pub-id-type="pmcid">PMC5324817</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>P</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D</given-names></name></person-group>. <article-title>Trends of reported human brucellosis cases in mainland China from 2007 to 2017: an exponential smoothing time series analysis</article-title>. <source>Environ Health Prev Med</source>. (<year>2018</year>) <volume>23</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/s12199-018-0712-5</pub-id><pub-id pub-id-type="pmid">29921215</pub-id><pub-id pub-id-type="pmcid">PMC6010161</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bian</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>LQ</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Qin</surname><given-names>YM</given-names></name><name name-style="western"><surname>Ding</surname><given-names>JB</given-names></name></person-group>. <article-title>Epidemiological trends and characteristics of Brucellosis in miscarriage dairy cows in China, 2013-2017</article-title>. <source>Microbiol China</source>. (<year>2019</year>) <volume>46</volume>:<fpage>618</fpage>&#8211;<lpage>23</lpage>.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Corbel</surname><given-names>MJ</given-names></name></person-group>. <article-title>Brucellosis vaccines: past, present and future</article-title>. <source>Vet Microbiol</source>. (<year>2002</year>) <volume>90</volume>:<fpage>479</fpage>&#8211;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1135(02)00255-9</pub-id><pub-id pub-id-type="pmid">12414166</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name></person-group>. <article-title>Treatment of brucellosis</article-title>. <source>BMJ</source>. (<year>2008</year>) <volume>336</volume>:<fpage>678</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.39497.431528.80</pub-id><pub-id pub-id-type="pmid">18321958</pub-id><pub-id pub-id-type="pmcid">PMC2276291</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avila-Calderon</surname><given-names>ED</given-names></name><name name-style="western"><surname>Lopez-Merino</surname><given-names>A</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><name name-style="western"><surname>Contreras-Rodriguez</surname><given-names>A</given-names></name></person-group>. <article-title>A history of the development of Brucella vaccines</article-title>. <source>Biomed Res Int</source>. (<year>2013</year>) <volume>2013</volume>:<fpage>743509</fpage>. <pub-id pub-id-type="doi">10.1155/2013/743509</pub-id><pub-id pub-id-type="pmid">23862154</pub-id><pub-id pub-id-type="pmcid">PMC3686056</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Q</given-names></name></person-group>. <article-title>The advances in brucellosis vaccines</article-title>. <source>Vaccine</source>. (<year>2019</year>) <volume>37</volume>:<fpage>3981</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.05.084</pub-id><pub-id pub-id-type="pmid">31176541</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xin</surname><given-names>X</given-names></name></person-group>. <article-title>Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine</article-title>. <source>Vaccine</source>. (<year>1986</year>) <volume>4</volume>:<fpage>212</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/0264-410X(86)90131-3</pub-id><pub-id pub-id-type="pmid">3541425</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di</surname><given-names>DD</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Tian</surname><given-names>LL</given-names></name><name name-style="western"><surname>Kang</surname><given-names>JL</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Yi</surname><given-names>XP</given-names></name><etal/></person-group>. <article-title>Comparative genomic analysis between newly sequenced Brucella suis Vaccine Strain S2 and the Virulent Brucella suis Strain 1330</article-title>. <source>BMC Genomics</source>. (<year>2016</year>) <volume>17</volume>:<fpage>741</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-016-3076-5</pub-id><pub-id pub-id-type="pmid">27645563</pub-id><pub-id pub-id-type="pmcid">PMC5029015</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Brucella suis strain 2 vaccine is safe and protective against heterologous <italic toggle="yes">Brucella</italic> spp. infections</article-title>. <source>Vaccine</source>. (<year>2016</year>)<volume>34</volume>:<fpage>395</fpage>&#8211;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.09.116</pub-id><pub-id pub-id-type="pmid">26626213</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Global Times News</collab></person-group>. <article-title>3,245 people have been infected by a brucellosis incident at LVRI</article-title> (<year>2020</year>). Available online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dy.163.com/article/FMJKVI7O05504DPG.html">https://dy.163.com/article/FMJKVI7O05504DPG.html</ext-link></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Chinese Veterinary Pharmacopoeia Committee</collab></person-group>. <source>Chinese Veterinary Pharmacopoeia (Version 2015)</source>.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name><name name-style="western"><surname>Papadimitriou</surname><given-names>P</given-names></name><name name-style="western"><surname>Akritidis</surname><given-names>N</given-names></name><name name-style="western"><surname>Christou</surname><given-names>L</given-names></name><name name-style="western"><surname>Tsianos</surname><given-names>EV</given-names></name></person-group>. <article-title>The new global map of human brucellosis</article-title>. <source>Lancet Infect Dis.</source> (<year>2006</year>) <volume>6</volume>:<fpage>91</fpage>&#8211;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(06)70382-6</pub-id><pub-id pub-id-type="pmid">16439329</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al Dahouk</surname><given-names>S</given-names></name><name name-style="western"><surname>N&#246;ckler</surname><given-names>K</given-names></name></person-group>. <article-title>Implications of laboratory diagnosis on brucellosis therapy</article-title>. <source>Expert Rev Anti Infect Ther.</source> (<year>2011</year>) <volume>9</volume>:<fpage>833</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1586/eri.11.55</pub-id><pub-id pub-id-type="pmid">21810055</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>G</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Pei</surname><given-names>X</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Z</given-names></name></person-group>. <article-title>Transmission dynamics of brucellosis: mathematical modelling and applications in China</article-title>. <source>Comput Struct Biotechnol J</source>. (<year>2020</year>) <volume>18</volume>:<fpage>3843</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.csbj.2020.11.014</pub-id><pub-id pub-id-type="pmid">33335683</pub-id><pub-id pub-id-type="pmcid">PMC7720096</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Wei</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name></person-group>. <article-title>Investigation of genetic relatedness of Brucella strains in countries along the Silk Road</article-title>. <source>Front Vet Sci</source>. (<year>2021</year>) <volume>7</volume>:<fpage>539444</fpage>. <pub-id pub-id-type="doi">10.3389/fvets.2020.539444</pub-id><pub-id pub-id-type="pmid">33490123</pub-id><pub-id pub-id-type="pmcid">PMC7817895</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>K</given-names></name><name name-style="western"><surname>Wu</surname><given-names>B</given-names></name><name name-style="western"><surname>Pan</surname><given-names>H</given-names></name><name name-style="western"><surname>Paudya</surname><given-names>N</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>ONE Health approach to address zoonotic brucellosis: a spatiotemporal associations study between animals and humans</article-title>. <source>Front Vet Sci</source>. (<year>2020</year>) <volume>7</volume>:<fpage>521</fpage>. <pub-id pub-id-type="doi">10.3389/fvets.2020.00521</pub-id><pub-id pub-id-type="pmid">32984409</pub-id><pub-id pub-id-type="pmcid">PMC7492289</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>O'Callaghan Ding</surname><given-names>J</given-names></name></person-group>. <article-title>Brucellosis in China: history, progress and challenge</article-title>. <source>Infect Dis Poverty</source>. (<year>2020</year>) <volume>9</volume>: <fpage>55</fpage>. <pub-id pub-id-type="doi">10.1186/s40249-020-00673-8</pub-id><pub-id pub-id-type="pmid">32448394</pub-id><pub-id pub-id-type="pmcid">PMC7247241</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perkins</surname><given-names>SD</given-names></name><name name-style="western"><surname>Smither</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Atkins</surname><given-names>HS</given-names></name></person-group>. <article-title>Towards a Brucella vaccine for humans</article-title>. <source>FEMS Microbiol Rev</source>. (<year>2010</year>) <volume>34</volume>:<fpage>379</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6976.2010.00211.x</pub-id><pub-id pub-id-type="pmid">20180858</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalsiamthara</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group>. <article-title>Development and trial of vaccines against Brucella</article-title>. <source>J Vet Sci</source>. (<year>2017</year>) <volume>18</volume>:<fpage>281</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.4142/jvs.2017.18.S1.281</pub-id><pub-id pub-id-type="pmid">28859268</pub-id><pub-id pub-id-type="pmcid">PMC5583415</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Dong</surname><given-names>H</given-names></name><name name-style="western"><surname>Peng</surname><given-names>X</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Niu</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Transcriptome analysis of gene expression profiling of infected macrophages between <italic toggle="yes">Brucella</italic>suis 1330 and live attenuated vaccine strain S2 displays mechanistic implication for regulation of virulence</article-title>. <source>MicrobPathog</source>. (<year>2018</year>) <volume>119</volume>:<fpage>241</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2018.04.003</pub-id><pub-id pub-id-type="pmid">29626657</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Comparative transcriptome analysis of artificially induced rough-mutant brucella strain RM57 and its parent strain <italic toggle="yes">Brucella melitensis</italic> M1981</article-title>. <source>Front Vet Sci.</source> (<year>2020</year>) <volume>6</volume>:<fpage>459</fpage>. <pub-id pub-id-type="doi">10.3389/fvets.2019.00459</pub-id><pub-id pub-id-type="pmid">31998758</pub-id><pub-id pub-id-type="pmcid">PMC6966878</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adetula</surname><given-names>AA</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Thi</surname><given-names>TNT</given-names></name><name name-style="western"><surname>Bhuiyan</surname><given-names>AA</given-names></name><name name-style="western"><surname>Du</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Transcriptional profiling of leucocyte count variation from porcine peripheral blood reveals differential gene expression</article-title>. <source>Biomed Res Int.</source> (<year>2018</year>) <volume>18</volume>:<fpage>1496536</fpage>. <pub-id pub-id-type="doi">10.1155/2018/1496536</pub-id><pub-id pub-id-type="pmid">30581844</pub-id><pub-id pub-id-type="pmcid">PMC6276489</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Majewska</surname><given-names>A</given-names></name><name name-style="western"><surname>Gajewska</surname><given-names>M</given-names></name><name name-style="western"><surname>Dembele</surname><given-names>K</given-names></name><name name-style="western"><surname>Maciejewski</surname><given-names>H</given-names></name><name name-style="western"><surname>Prostek</surname><given-names>A</given-names></name><name name-style="western"><surname>Jank</surname><given-names>M</given-names></name></person-group>. <article-title>Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis</article-title>. <source>BMC Vet Res</source>. (<year>2016</year>) <volume>12</volume>:<fpage>174</fpage>. <pub-id pub-id-type="doi">10.1186/s12917-016-0805-6</pub-id><pub-id pub-id-type="pmid">27553600</pub-id><pub-id pub-id-type="pmcid">PMC4995625</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tariq</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">De Novo</italic> transcriptomic analysis of peripheral blood lymphocytes from the Chinese goose: gene discovery and immune system pathway description</article-title>. <source>PLoS ONE</source>. (<year>2015</year>) <volume>10</volume>:<fpage>e0121015</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0121015</pub-id><pub-id pub-id-type="pmid">25816068</pub-id><pub-id pub-id-type="pmcid">PMC4376690</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Xing</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>W</given-names></name></person-group>. <article-title>Transcriptome analysis of immune response of mIgM+ B lymphocytes in Japanese flounder (paralichthysolivaceus) to lactococcus lactis <italic toggle="yes">in vitro</italic> revealed that IFN I-3 could enhance their phagocytosis</article-title>. <source>Front. Immunol</source>. (<year>2019</year>) <volume>10</volume>:<fpage>1622</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01622</pub-id><pub-id pub-id-type="pmid">31379827</pub-id><pub-id pub-id-type="pmcid">PMC6646603</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Granata</surname><given-names>S</given-names></name><name name-style="western"><surname>Santoro</surname><given-names>G</given-names></name><name name-style="western"><surname>Signorini</surname><given-names>L</given-names></name><name name-style="western"><surname>Malerba</surname><given-names>G</given-names></name><name name-style="western"><surname>Patuzzo</surname><given-names>C</given-names></name><name name-style="western"><surname>Gambaro</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy</article-title>. <source>Eur J Pharmacol</source>. (<year>2019</year>) <volume>859</volume>:<fpage>172494</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2019.172494</pub-id><pub-id pub-id-type="pmid">31238062</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corbi</surname><given-names>SCT</given-names></name><name name-style="western"><surname>de Vasconcellos</surname><given-names>JF</given-names></name><name name-style="western"><surname>Bastos</surname><given-names>AS</given-names></name><name name-style="western"><surname>Bussaneli</surname><given-names>DG</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>BR</given-names></name><name name-style="western"><surname>Santos</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis</article-title>. <source>Sci Rep</source>. (<year>2020</year>) <volume>10</volume>:<fpage>8145</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-65042-9</pub-id><pub-id pub-id-type="pmid">32424199</pub-id><pub-id pub-id-type="pmcid">PMC7235087</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><name name-style="western"><surname>Guo</surname><given-names>M</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients</article-title>. <source>Emerg Microbes Infect</source>. (<year>2020</year>) <volume>9</volume>:<fpage>761</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1080/22221751.2020.1747363</pub-id><pub-id pub-id-type="pmid">32228226</pub-id><pub-id pub-id-type="pmcid">PMC7170362</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>